knowledge -WSS

knowledge

author：knowledge 2025-09-29 16:33:05 - browse：69516

CDC campus exterior -- first opinion coverage from STAT — ACIP, normally a 15-member panel, has eight vacancies, and four more coming soon. Why hasn't HHS signed off on the CDC's nominees? Adobe

A critical government advisory committee charged with charting U.S. vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country.

The Advisory Committee on Immunization Practices, which has in recent years been a 15-person panel, has eight vacancies — one of which dates back more than a year. The other seven members’ terms ended in July, though they were extended through the year because they had no replacements. There is no chairperson.

Four of the seven remaining members are due to finish their terms at the end of June, a cumulative exodus of expertise that will create what followers of the ACIP’s work believe is an unprecedented level of inexperience on the committee. Historically, three or four new members have been appointed to four-year terms every July, ensuring the roster always includes a mix of seasoned and new members.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Air quality improving but still lags in Black, Hispanic communities

hotspot

knowledge

WSS

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Amylyx ALS drug failure raises questions and concerns

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Sen. Paul opposes bill to ban Chinese biotechs

The problem with charging patients to message their doctors

Amylyx ALS drug fails large clinical trial

focus

knowledge

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

United colonoscopy coverage change 'may cost lives,' doctors say

Study: Hearing aids may slow cognitive decline in those at risk

United colonoscopy coverage change 'may cost lives,' doctors say

FDA seeking to stop procedures at two unregulated stem cell clinics

The high cost of giving birth even with insurance

The Readout: Amylyx, Alumis, and Lundbeck drug updates

DIEP, the 'gold standard' of breast reconstruction, is under threat

With psoriasis trial ahead, Alumis raises $259 million

hotspot

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Amylyx ALS drug failure raises questions and concerns

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Robert Kennedy Jr.'s presidential campaign attracts GOP

hotspot

knowledge

explore

focus